-
1 Comment
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd is currently in a long term downtrend where the price is trading 16.5% below its 200 day moving average.
From a valuation standpoint, the stock is 42.9% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 5.5.
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd's total revenue sank by 10.4% to $121M since the same quarter in the previous year.
Its net income has dropped by 17.3% to $18M since the same quarter in the previous year.
Finally, its free cash flow fell by 125.9% to $-10M since the same quarter in the previous year.
Based on the above factors, Anhui Sunhere Pharmaceutical Excipients Co.,Ltd gets an overall score of 1/5.
| ISIN | CNE100001ZH5 |
|---|---|
| Exchange | SHE |
| CurrencyCode | CNY |
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| PE Ratio | 24.49 |
|---|---|
| Dividend Yield | 2.1% |
| Beta | 0.26 |
| Target Price | 18 |
| Market Cap | 3B |
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. research and development, production, and sale of new pharmaceutical excipients in China. The company provides cellulose, starch, povidone, stearic acid, coating powder, resin, food additive, and other products. It also exports its products. The company was founded in 2001 and is based in Huainan, China.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 300452.SHE using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
